NeuBase Therapeutics Price Prediction
| NBSEDelisted Stock | USD 1.62 0.17 9.50% |
Oversold Vs Overbought
30
Oversold | Overbought |
Using NeuBase Therapeutics hype-based prediction, you can estimate the value of NeuBase Therapeutics from the perspective of NeuBase Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in NeuBase Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying NeuBase because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NeuBase Therapeutics after-hype prediction price | USD 1.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NeuBase |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeuBase Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NeuBase Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of NeuBase Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NeuBase Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NeuBase Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NeuBase Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting NeuBase Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NeuBase Therapeutics' historical news coverage. NeuBase Therapeutics' after-hype downside and upside margins for the prediction period are 1.62 and 1.62, respectively. We have considered NeuBase Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NeuBase Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of NeuBase Therapeutics is based on 3 months time horizon.
NeuBase Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as NeuBase Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NeuBase Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NeuBase Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 12 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.62 | 1.62 | 0.00 |
|
NeuBase Therapeutics Hype Timeline
NeuBase Therapeutics is now traded for 1.62. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NeuBase is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on NeuBase Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 1.62. About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeuBase Therapeutics recorded a loss per share of 18.6. The entity last dividend was issued on the 4th of February 2019. The firm had 1:20 split on the 15th of June 2023. Given the investment horizon of 90 days the next projected press release will be very soon. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.NeuBase Therapeutics Related Hype Analysis
Having access to credible news sources related to NeuBase Therapeutics' direct competition is more important than ever and may enhance your ability to predict NeuBase Therapeutics' future price movements. Getting to know how NeuBase Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NeuBase Therapeutics may potentially react to the hype associated with one of its peers.
NeuBase Therapeutics Additional Predictive Modules
Most predictive techniques to examine NeuBase price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NeuBase using various technical indicators. When you analyze NeuBase charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NeuBase Therapeutics Predictive Indicators
The successful prediction of NeuBase Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NeuBase Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NeuBase Therapeutics based on analysis of NeuBase Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NeuBase Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NeuBase Therapeutics's related companies.
Story Coverage note for NeuBase Therapeutics
The number of cover stories for NeuBase Therapeutics depends on current market conditions and NeuBase Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NeuBase Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NeuBase Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
NeuBase Therapeutics Short Properties
NeuBase Therapeutics' future price predictability will typically decrease when NeuBase Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NeuBase Therapeutics often depends not only on the future outlook of the potential NeuBase Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NeuBase Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 M | |
| Cash And Short Term Investments | 23.2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in NeuBase Stock
If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |